Missing Y gene linked to male infertility

Updated on: October 01,2025 0

Missing Y gene linked to male infertility

Updated on:October 01,2025 0

Stem cell scientists unlock blueprint for lab-grown kidney cells with preclinical value

Updated on: October 01,2025 0

Stem cell scientists unlock blueprint for lab-grown kidney cells with preclinical value

Updated on:October 01,2025 0

Using new blood biomarkers, researchers find Alzheimer's disease trial eligibility differs among various populations

Updated on: October 01,2025 0

Using new blood biomarkers, researchers find Alzheimer's disease trial eligibility differs among various populations

Updated on:October 01,2025 0

Bursting HIV's bubble: A new workflow to study HIV-1 genome-containing capsids

Updated on: October 01,2025 0

Bursting HIV's bubble: A new workflow to study HIV-1 genome-containing capsids

Updated on:October 01,2025 0

New tool helps identify unreliable research trials

Updated on: October 01,2025 0

New tool helps identify unreliable research trials

Updated on:October 01,2025 0

3D structure of human clusterin sheds light on Alzheimer's risk factor

Updated on: October 01,2025 0

3D structure of human clusterin sheds light on Alzheimer's risk factor

Updated on:October 01,2025 0

Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer

Updated on: September 30,2025 0

Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer

Updated on:September 30,2025 0

Depression remission endures five years after psilocybin trial

Updated on: September 30,2025 0

Depression remission endures five years after psilocybin trial

Updated on:September 30,2025 0

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on: September 30,2025 0

Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial

Updated on:September 30,2025 0

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer

Updated on: September 30,2025 0

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer

Updated on:September 30,2025 0